ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares OverviewProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares Total Revenue
Revenue analysis for BIB.
Quarterly Revenue
$3.08M
↓ 43.23% YoY
As of Dec 2025
Annual Revenue (TTM)
$13.06M
↑ 4.2% YoY
Trailing 12 months ending Dec 2025
Average Revenue (Comparison Companies)
Total Revenue History
Total Revenue Comparison
Annual Revenue Growth Rate (%)
Annual Revenue Growth (Absolute)